Article

Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined…

Stem Cells International · 2021 · Eleni Gounari, author Anastasia Komnenou, author Evangelia Kofidou, author Stavroula Nanaki, author Dimitrios Bikiaris, author Stavroula Almpanidou, author Kokkona Kouzi, author Vasileios Karampatakis, author George Koliakos, author Isotta Chimenti, Academic Editor

Key facts

Title Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion
First author Eleni Gounari, author Anastasia Komnenou, author Evangelia Kofidou, author Stavroula Nanaki, author Dimitrios Bikiaris, author Stavroula Almpanidou, author Kokkona Kouzi, author Vasileios Karampatakis, author George Koliakos, author Isotta Chimenti, Academic Editor
Journal Stem Cells International
Published May 27, 2021
DOI 10.1155/2022/2760147
Devices mentioned K800552, K853723, K860811, K862004, K874160, K874609, K912581, K912666, K915561, K915840, K920529, K920967 and 11 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, LIQ

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature